These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1926044)

  • 21. [Hirudin and other thrombin inhibitors from blood-sucking animals].
    Landmann H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1972; 98(4):437-45. PubMed ID: 4121337
    [No Abstract]   [Full Text] [Related]  

  • 22. [The pharmacology of recombinant hirudin].
    Kaiser B
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(6):841-9. PubMed ID: 2483701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Coagulation inhibition caused by selective thrombin blockade with hirudin].
    Klöss T; Lorenz W; Meyer U; Mittmann U; Neugebauer E; Saggau WW
    Chir Forum Exp Klin Forsch; 1978; (1978):143-8. PubMed ID: 752579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Laboratory use of hirudin.
    Stocker K
    Semin Thromb Hemost; 1991 Apr; 17(2):113-21. PubMed ID: 1722908
    [No Abstract]   [Full Text] [Related]  

  • 25. Pre-clinical and clinical studies on Hirulog: a potent and specific direct thrombin inhibitor.
    Maraganore JM
    Adv Exp Med Biol; 1993; 340():227-36. PubMed ID: 8154339
    [No Abstract]   [Full Text] [Related]  

  • 26. The anticoagulant and antithrombotic properties of hirudins.
    Märki WE; Wallis RB
    Thromb Haemost; 1990 Nov; 64(3):344-8. PubMed ID: 2096484
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of new synthetic heparin mimetics on whole blood thrombin generation in vivo and in vitro in rats.
    Hérault JP; Bernat A; Gaich C; Herbert M
    Thromb Haemost; 2002 Feb; 87(2):238-44. PubMed ID: 11858483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Recent developments in the biochemistry of hirudins].
    Walsmann P
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(6):821-30. PubMed ID: 2483699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and characterization of more potent analogues of hirudin fragment 1-47 containing non-natural amino acids.
    De Filippis V; Quarzago D; Vindigni A; Di Cera E; Fontana A
    Biochemistry; 1998 Sep; 37(39):13507-15. PubMed ID: 9753436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Additive effect of the combined administration of low molecular weight heparin and recombinant hirudin on thrombus growth in a rabbit jugular vein thrombosis model.
    Biemond BJ; Levi M; Nurmohamed MT; Büller HR; ten Cate JW
    Thromb Haemost; 1994 Sep; 72(3):377-80. PubMed ID: 7855787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RGD-hirudin-based low molecular weight peptide prevents blood coagulation via subcutaneous injection.
    Li YR; Huang YN; Zhao B; Wu MF; Li TY; Zhang YL; Chen D; Yu M; Mo W
    Acta Pharmacol Sin; 2020 Jun; 41(6):753-762. PubMed ID: 31949293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hirudin--comeback of Hirudo medicinalis].
    Lassila R
    Duodecim; 1992; 108(6):535-7. PubMed ID: 1366111
    [No Abstract]   [Full Text] [Related]  

  • 33. [Biological activity of pharmacological properties of the anticoagulant complex (hirudin, plasma kallikrein inhibitor, prostaglandin) from the leech Hirudo medicinalis].
    Nikonov GI; Titova EA; Seleznev KG
    Biull Eksp Biol Med; 1999 Dec; 128(12):673-6. PubMed ID: 10650471
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacological approaches to thrombin regulation.
    Markwardt F
    Ann N Y Acad Sci; 1986; 485():204-14. PubMed ID: 3551729
    [No Abstract]   [Full Text] [Related]  

  • 35. CX-397, a novel recombinant hirudin analog having a hybrid sequence of hirudin variants-1 and -3.
    Komatsu Y; Misawa S; Sukesada A; Ohba Y; Hayashi H
    Biochem Biophys Res Commun; 1993 Oct; 196(2):773-9. PubMed ID: 8240353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel stearic acid-modified hirudin peptidomimetic with improved pharmacokinetic properties and anticoagulant activity.
    Liu Z; Yu Z; Huang Y; Zhang Y; Han G; Li X; Dong M; Yu S; Wang Y; Hu J; Guo H; Cheng Y; Lv L; Dai Q
    Sci Rep; 2015 Sep; 5():14349. PubMed ID: 26400022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of MDL 28,050, a small stable antithrombin agent based on a functional domain of the leech protein, hirudin.
    Krstenansky JL; Broersma RJ; Owen TJ; Payne MH; Yates MT; Mao SJ
    Thromb Haemost; 1990 Apr; 63(2):208-14. PubMed ID: 2363122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of hirudin versus heparin on hemocompatibility of blood contacting biomaterials: an in vitro study.
    Kopp R; Bernsberg R; Kashefi A; Mottaghy K; Rossaint R; Kuhlen R
    Int J Artif Organs; 2005 Dec; 28(12):1272-7. PubMed ID: 16404704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of different anticoagulants on thrombin generation.
    Petros S; Siegemund T; Siegemund A; Engelmann L
    Blood Coagul Fibrinolysis; 2006 Mar; 17(2):131-7. PubMed ID: 16479195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Self-regulated hirudin delivery for anticoagulant therapy.
    Xu X; Huang X; Zhang Y; Shen S; Feng Z; Dong H; Zhang C; Mo R
    Sci Adv; 2020 Oct; 6(41):. PubMed ID: 33036973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.